Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin; Richard Haynes; PK Judge; Christoph Wanner; Julie Green; Jonathan Emberson; David Preiss; KJ Mayne; SYA Ng; Emily Sammons; Dandan Zhu; Michael Hill; W. Grant Stevens; Karl Wallendszus; AK Cheung; Zhihong Liu; J Li; LS Hooi; Wenjun Liu; Takashi Kadowaki; Masaomi Nangaku; Adeera Levin; David Z.I. Cherney; Aldo Maggioni; Roberto Pontremoli; Rajat Deo; Shinichi Goto; Xavier Rosselló; Katherine R. Tuttle; Dominik Steubl; Michaela Petrini; Siegfried Seidi; Martin Landray; Colin Baigent; WG Herrington; Sharirose Abat; Riaz Rahman; Rizna Abdul Cader; MI Abdul Hafidz; MZ Abdul Wahab; NK Abdullah; Talal Abdulsamad; Masami Abe; Ned Abraham; Sarah Acheampong; P Achiri; JA Acosta; A A Adeleke; Vicki Adell; R Adewuyi-Dalton; Nihad Adnan; A Africano; Mohsen Agharazii; Frank G. Aguilar; A Aguilera; Ahmad Mukhtar; MK Ahmad; NA Ahmad; NH Ahmad; NI Ahmad; Norazinizah Ahmad Miswan; H Ahmad Rosdi; Iffat Ahmed; Sofia B. Ahmed; Sofia B. Ahmed; Joan Aiello; Alastair Aitken; R AitSadi; Sendogan Aker; S Akimoto; Akinwande A. Akinfolarin; S. Akram; Federico Alberici; Christian Albert; Luke Aldrich; M Alegata; Lacy M. Alexander; S Alfaress; Mohammad Alhadj Ali; Radica Z. Alicic; Arta Aliu; Ricardo López Almaraz; Rashid Almasarwah; Jussara Carnevale de Almeida; Alessia Aloisi; Laith Al‐Rabadi; Mark Dominik Alscher; Pedro Álvarez; Bader Al-Zeer; M. Ochoa de Olza Amat; Christopher S. Ambrose; Hany Ammar; Yu An; L Andriaccio; K Ansu; A Apostolidi; N. Arai

doi:10.1016/s2213-8587(23)00321-2

Related publications

Article2023

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner, Julie Green, SJ Hauske, Jonathan Emberson, David Preiss, SYA Ng, AJ Roddick, Emily Sammons, Dandan Zhu, Michael Hill, W. Grant Stevens, Karl Wallendszus, Susanne Brenner, AK Cheung, Zhihong Liu, J Li, LS Hooi, Wenjun Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Z.I. Cherney, Aldo Maggioni, Roberto Pontremoli, Rajat Deo, Shinichi Goto, Xavier Rosselló, Katherine R. Tuttle, Dominik Steubl, Daisy Massey, Martin Landray, Colin Baigent, Richard Haynes, WG Herrington, S Abat, Riaz Rahman, Rizna Abdul Cader, MI Abdul Hafidz, MZ Abdul Wahab, NK Abdullah, Talal Abdulsamad, Masanori Abe, Nader G. Abraham, Sarah Acheampong, P Achiri, JA Acosta, A. Q. Adeleke, Vicki Adell, R Adewuyi-Dalton, Nihad Adnan, A Africano, Mohsen Agharazii, Frank G. Aguilar, A Aguilera, Movahedian Ahmad, MK Ahmad, NA Ahmad, NH Ahmad, NI Ahmad, Norazinizah Ahmad Miswan, H Ahmad Rosdi, Iffat Ahmed, Sofia B. Ahmed, Sofia B. Ahmed, Joan Aiello, A. Aitken, R AitSadi, Sendogan Aker, S Akimoto, A Akinfolarin, S. Akram, Federico Alberici, Christian Albert, Leslie N. Aldrich, M Alegata, Lee Alexander, S Alfaress, Mohammad Alhadj Ali, Ahmed Issam Ali, Ahmed Issam Ali, Radica Z. Alicic, A Aliu, Ricardo López Almaraz, Rashid Almasarwah, Jussara Carnevale de Almeida, Alessia Aloisi, Laith Al‐Rabadi, Mark Dominik Alscher, Pedro Álvarez, Bader Al-Zeer, Mora Amat, Christopher S. Ambrose, Hany Ammar, Yu An, L Andriaccio, Kwame Ansu, A Apostolidi

Article2022

Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The <scp>ELIXA</scp> trial

Hertzel C. Gerstein, Emil Wolsk, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Marc A. Pfeffer

Article2018

Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

M. Angelyn Bethel, Robert J. Mentz, Peter Merrill, John B. Buse, Juliana C.N. Chan, Shaun G. Goodman, Nayyar Iqbal, Neli Jakubonienė, Brian G. Katona, Yuliya Lokhnygina, Renato D. Lópes, Aldo Maggioni, Peter K. Öhman, Neil R Poulter, Ambady Ramachandran, Tsvetalina Tankova, Bernard Zinman, Adrian F. Hernandez, Rury R. Holman

Article2020

1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event

Magnus Wijkman, Brian Claggett, Rafael Díaz, Hertzel C. Gerstein, Lars Køber, Eldrin Lewis, Aldo Maggioni, Emil Wolsk, David Aguilar, Rhonda Bentley–Lewis, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Scott Solomon, Marc A. Pfeffer

Letter2021

Describing the burden of the COVID‐19 pandemic in people with psoriasis: findings from a global cross‐sectional study

Satveer K. Mahil, Mark Yates, Zenas Z N Yiu, Sinéad Langan, Teresa Tsakok, Nick Dand, K.J. Mason, Helen McAteer, Freya Meynell, Bola Coker, Alexandra Vincent, Dominic Urmston, A Vesty, J Kelly, Camille Lancelot, Lucy Moorhead, H. Bachelez, Francesca Capon, Claudia Romina Contreras, C. Cruz, Paola Di Meglio, Paolo Gisondi, D. Jullien, Jo Lambert,